Endostar protein clinical trials
Also written Endostar.
How each study uses endostar protein is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the endostar protein studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
92 studies that test it; most in 2020 (8)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2000 | 1 |
| 2003 | 1 |
| 2007 | 3 |
| 2008 | 6 |
| 2009 | 6 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 3 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 6 |
| 2016 | 7 |
| 2017 | 6 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 8 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 6 |
| 2025 | 1 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 11 · Other 81
Zhejiang Cancer Hospital (9) · Fudan University (7) · Jiangsu Simcere Pharmaceutical Co., Ltd. (6) · Simcere Pharmaceutical Co., Ltd (6) · First Affiliated Hospital of Guangxi Medical University (4) · Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd (3) · Shanghai Jiao Tong University School of Medicine (2) · The First People's Hospital of Lianyungang (2)
Often tested with
Tested in the same studies.
Envafolimab (9) · Docetaxel (6) · Cisplatin (3) · Carboplatin (3) · Pemetrexed (3) · Toripalimab (3) · Gemcitabine (3) · Nedaplatin (2)
Related medicines
As reviewed, each with the page that says it.
- One of Angiogenesis inhibitors source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test endostar protein.
- Feb 2027Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.Phase 2 · Chongqing University Cancer Hospital
Studies
Open first, then newest update. How each study uses endostar protein is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 92
- Early Prophylactic Versus Late Salvage Recombinant Human Endostatin in Managing Radiosurgery-Induced Brain Injury for NSCLC Brain MetastasesNot yet recruitingPhase 2Jiangmen Central HospitalNCT07841106Written as Recombinant Human Endostatin (Endostar)How we know
- SRT Combined With Envafolimab and Endostar in the First-line Treatment of Advanced NSCLCNot yet recruitingPhase 2The First People's Hospital of LianyungangNCT07818304Written as EndostarHow we know
- Platinum-Free Regimen in Nasopharyngeal CarcinomaNot yet recruitingPhase 2Zhejiang Cancer HospitalNCT07794488Written as Endostar (recombinant human endostatin injection)How we know
- Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.RecruitingPhase 2Chongqing University Cancer HospitalNCT06059261Written as Envafolimab and recombinant human endostatin combined with chemoradiotherapyHow we know
- Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.RecruitingPhase 2Hua ZhangNCT06617936Written as neoadjuvant therapy:Tislelizumab With Recombinant human endostatin combined with ChemotherapyHow we know
- Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II TrialRecruitingPhase 2Fudan UniversityNCT06965231Written as Toripalimab combined with EndostarHow we know
- Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent GliomasRecruitingPhase 2Beijing Sanbo Brain HospitalNCT04267978Written as recombinant human endostatin,temozolomide,irinotecanHow we know
- Local Injection and Systemic Therapy in the Treatment of NSCLC.Not yet recruitingPhase 2Henan Cancer HospitalNCT06618391Written as Recombinant human endostatinHow we know
- GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPCNot yet recruitingPhase 2Zhejiang Cancer HospitalNCT06611826Written as GEP (Gemcitabine, Recombinant Human Endostatin, and Carrellizumab) Combined With High-low-dose RadiotherapyHow we know
- Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal TumorsRecruitingPhase 2Nanjing First Hospital, Nanjing Medical UniversityNCT06301828Written as EndostarHow we know
- Recombinant Human Endostatin Combined With Envafolimab and Synchronal RadiochemotherapyNot yet recruitingPhase 2The First Affiliated Hospital of Xinxiang Medical CollegeNCT06279754Written as Recombinant Human Endostatin InjectionHow we know
- Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLCRecruitingPhase 2The First People's Hospital of LianyungangNCT05203276Written as EndostarHow we know
- Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous MelanomaRecruitingPhase 2Fudan UniversityNCT05907512Written as EndostarHow we know
- Endostar Combined With Corticosteroid for Treatment of Radiation-induced Brain Necrosis in Nasopharyngeal CarcinomaRecruitingPhase 2Jiangxi Provincial Cancer HospitalNCT05177237Written as EndostarHow we know
- Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy for Nasopharyngeal CarcinomaNot yet recruitingPhase 2First Affiliated Hospital of Guangxi Medical UniversityNCT04447326Written as Toripalimab, Endostar Combined With Radiotherapy and ChemotherapyHow we know
- Postoperative Concurrent Chemoradiotherapy Combined With Endostar for High-risk Early Stage Cervical CancerRecruitingPhase 2Nanjing Medical UniversityNCT03622827Written as Chemoradiotherapy+ EndostarHow we know
- Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal CarcinomaActive, not recruitingPhase 2Zhejiang Cancer HospitalNCT06055816Written as Endostar and EnvafolimabHow we know
- Intra-arterial Cisplatin Plus Rh-endostatin Combined With Systematic Chemotherapy in OsteosarcomaCompletedPhase 1/2Shanghai 6th People's HospitalNCT06562673Written as intra-arterial cisplatin plus anti-angiogenesis inhibitor rh-endostatin (Endostar)How we know
- Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical CarcinomaCompletedPhase 2Yong Zhang,MDNCT03086681Written as EndostarHow we know
- Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell CarcinomasCompletedPhase 2Fudan UniversityNCT03797625Written as EndostarHow we know
See all 92 studies that test endostar protein →
Given beside what is tested · 6 — endostar protein is usual care or a partner of the new treatment
- Modified CV Regimen in Optic Pathway GliomaRecruitingPhase 2Beijing Sanbo Brain HospitalNCT05278715Written as Recombinant human endostatinHow we know
- Second-Line Chemotherapy Combined With Endostatin for Recurrent/Metastatic HN Epithelial TumorsStatus unknownPhase 2Sun YanNCT03989830Written as Recombinant human endostatinHow we know
- Maintenance Treatment of Toripalimab(JS001) in Patients With Unresectable Locally Advanced or Metastatic Mucosal MelanomaStatus unknownPhase 2Fudan UniversityNCT04472806Written as chemotherapy in combination with EndostarHow we know
- Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC PatientsStatus unknownPhase 3Xinqiao Hospital of ChongqingNCT02579564Written as EndostarHow we know
- Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical ResearchStatus unknownPhase 4Nanjing NingQi Medicine Science and Technology Co., Ltd.NCT02513355Written as EndostarHow we know
- Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric CancerCompletedPhase 2Peking UniversityNCT00842491Written as endostar, cisplatin, capecitabineHow we know
Codes
What other systems call endostar protein · ClinicalTrials.gg INT005158
- MeSH (NLM) C522911endostar proteinConfirmed ClinicalTrials.gov, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C522911 | endostar protein | Confirmed ClinicalTrials.gov, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.